Analysts’ Viewpoint on Global Market Scenario
Increasing gastrointestinal disorders, technological advancements, rising investments in human microbiome projects in developing countries, and lucrative presence of market players across the globe are factors responsible for the rapid expansion of global human microbiome market. The growing awareness about women health is also driving the global market for human microbiome. Market stakeholders are extending their services arms by developing innovative and technologically advanced products in order to gain revenue benefits. Market players operating in the global market should focus on the challenges associated with the clinical trial setbacks, some regulatory hurdles, and privacy Issues in diagnostics to stay afloat in the business. In addition, companies in the global human microbiome industry should accelerate their product development and unlock revenue opportunities to obtain competitive benefits.
The microbiome is a genetic component of various microorganisms such as bacteria, fungi, protozoa, and viruses, which live inside and on the human body. The rising knowledge about the benefits of the bacteria present in the microbiome for better digestion of food, regulation of the immune system, and protection against other disease-causing bacteria is fueling the growth of the global human microbiome market. Manufacturers operating in the global market for human microbiomes are developing diagnostic and therapeutic products. The increasing research & development activities in the field of this market are contributing to the growth of the global human microbiome business.
Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing simple and cost-effective, paving the way to carry out rapid analysis of the genomic content of microorganisms from human samples. This has strengthened the development process for microbiome-based diagnostics. Gastrointestinal and metabolic disorders are likely to capture the leading share of the diagnostics market. Due to the rise in focus of companies toward developing an easy analysis platform for gut health-based disorders, such as irritable bowel syndrome and Crohn’s disease. Rising efforts by manufacturers to develop non-invasive tests create potential opportunities for market growth.
Among technologies, the global human microbiome market has been divided into metagenomic sequencing and 16s rRNA sequencing. The metagenomic sequencing segment is expected to account for the largest share of the global market for human microbiomes. This growth can be attributed to the rising penetration of small-scale product manufacturers across the globe. These players are engaged in providing comprehensive data profiles of the inherent microbiome of the individual being tested. There are rising investments by companies operating in the human microbiome industry. Increasing partnerships and collaborative activities by market players to offer technology-driven products are anticipated to propel the segment during the forecast period.
The growth of the global human microbiome market can be attributed to the increasing prevalence of gastrointestinal & metabolic disorders. The growing awareness about the severity of chronic diseases such as cancer driving the expansion of the global market. Major market players in the microbiome diagnostics segment are launching innovative products to cure several common gut problems, Crohn’s disease, and ulcerative colitis. The growth of the segment can be attributed to the high number of microbiome diagnostic companies and the ease of non-invasive testing provided by this method.
Due to the increase in investments in research & development, ongoing clinical trials for developing microbiome-based therapies, stringent governmental regulations, and rapid technological advancements, North America is expected to dominate the global market for human microbiomes in the upcoming years. The growing awareness about the benefits of microbiome-based products among consumers is escalating the demand for these products. A large number of market players working in North America is a major driving factor for the. The increasing efforts by governments to promote human microbiome products are contributing to the expansion of the North American market for human microbiome, creating value-grab opportunities for market players.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 1.3 Bn |
|
Market Forecast Value in 2028 |
US$ 2.2 Bn |
|
Growth Rate (CAGR) |
7.1% (Year-on-Year) |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross-segment and regional-level analysis. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and a parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Human Microbiome Market – Segmentation
| Indication |
|
| Technology |
|
| Therapeutic Area |
|
| Region |
|
The global market was worth US$ 1.3 Bn and is projected to reach a value of US$ 2.2 Bn by the end of 2028
The human microbiome market is anticipated to grow at a CAGR of 7.1% during the forecast period
North America accounted for a major share of the global market
Global market for human microbiome is driven by a rise in venture capital investments, and the surge in the financing of the microbiome projects is projected to drive the global market during the forecast period
Key players in the global market include AOBiome, Enterome Biosciences SA, Metabiomics Corp. (BioSpherex LLC), Microbiome Therapeutics LLC, Osel, Inc., Second Genome, Seres Therapeutics, Synthetic Biologics, Inc., Vedanta Biosciences, 4D Pharma, and Ferring Pharmaceuticals
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Human Microbiome Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Human Microbiome Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. COVID-19 Impact on the Human Microbiome Market
5.2. Microbiome Therapeutics Pipeline Scenario
5.3. Regulatory Scenario across globe
5.4. Impact of human microbiome therapeutics on current treatment options
5.5. Key Mergers & Acquisitions
6. Global Human Microbiome Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Human Microbiome Market Value Forecast, by Indication, 2017–2028
6.2.1. Gastrointestinal & Metabolic Disorders
6.2.2. Women's Health
6.2.3. Cancer
6.2.4. Others
6.3. Global Human Microbiome Market Attractiveness Analysis, by Indication
6.4. Global Human Microbiome Market Analysis and Forecast, by Technology
6.4.1. Introduction & Definition
6.4.2. Key Findings / Developments
6.5. Global Human Microbiome Market Value Forecast, by Technology, 2017–2028
6.5.1. 16s rRNA Sequencing
6.5.2. Metagenomic Sequencing
6.6. Global Human Microbiome Market Attractiveness Analysis, by Technology
7. Global Human Microbiome Market Analysis and Forecast, by Therapeutic Area
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Human Microbiome Market Value Forecast, by Therapeutic Area, 2017–2028
7.2.1. Gastrointestinal Disorders
7.2.2. Metabolic Disorders
7.2.3. Women's Health Disorders
7.2.4. Skin Disorders
7.2.5. Others
7.3. Global Human Microbiome Market Attractiveness Analysis, by Therapeutic Area
8. Global Human Microbiome Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Human Microbiome Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Human Microbiome Market Attractiveness Analysis, by Region
9. North America Human Microbiome Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
9.2.1. Gastrointestinal & Metabolic Disorders
9.2.2. Women's Health
9.2.3. Cancer
9.2.4. Others
9.3. North America Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
9.3.1. 16s rRNA Sequencing
9.3.2. Metagenomic Sequencing
9.4. North America Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
9.4.1. Gastrointestinal Disorders
9.4.2. Metabolic Disorders
9.4.3. Women's Health Disorders
9.4.4. Skin Disorders
9.4.5. Others
9.5. North America Human Microbiome Market Value (US$ Mn) Forecast, by Country, 2017–2028
9.5.1. U.S.
9.5.2. Canada
9.6. North America Human Microbiome Market Attractiveness Analysis
9.6.1. By Indication
9.6.2. By Technology
9.6.3. By Therapeutic Area
9.6.4. By Country
10. Europe Human Microbiome Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
10.2.1. Gastrointestinal & Metabolic Disorders
10.2.2. Women's Health
10.2.3. Cancer
10.2.4. Others
10.3. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
10.3.1. 16s rRNA Sequencing
10.3.2. Metagenomic Sequencing
10.4. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
10.4.1. Gastrointestinal Disorders
10.4.2. Metabolic Disorders
10.4.3. Women's Health Disorders
10.4.4. Skin Disorders
10.4.5. Others
10.5. Europe Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Europe Human Microbiome Market Attractiveness Analysis
10.6.1. By Indication
10.6.2. By Technology
10.6.3. By Therapeutic Area
10.6.4. By Country/Sub-region
11. Asia Pacific Human Microbiome Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
11.2.1. Gastrointestinal & Metabolic Disorders
11.2.2. Women's Health
11.2.3. Cancer
11.2.4. Others
11.3. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
11.3.1. 16s rRNA Sequencing
11.3.2. Metagenomic Sequencing
11.4. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
11.4.1. Gastrointestinal Disorders
11.4.2. Metabolic Disorders
11.4.3. Women's Health Disorders
11.4.4. Skin Disorders
11.4.5. Others
11.5. Asia Pacific Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Human Microbiome Market Attractiveness Analysis
11.6.1. By Indication
11.6.2. By Technology
11.6.3. By Therapeutic Area
11.6.4. By Country/Sub-region
12. Latin America Human Microbiome Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
12.2.1. Gastrointestinal & Metabolic Disorders
12.2.2. Women's Health
12.2.3. Cancer
12.2.4. Others
12.3. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
12.3.1. 16s rRNA Sequencing
12.3.2. Metagenomic Sequencing
12.4. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
12.4.1. Gastrointestinal Disorders
12.4.2. Metabolic Disorders
12.4.3. Women's Health Disorders
12.4.4. Skin Disorders
12.4.5. Others
12.5. Latin America Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Human Microbiome Market Attractiveness Analysis
12.6.1. By Indication
12.6.2. By Technology
12.6.3. By Therapeutic Area
12.6.4. By Country/Sub-region
13. Middle East & Africa Human Microbiome Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Indication, 2017–2028
13.2.1. Gastrointestinal & Metabolic Disorders
13.2.2. Women's Health
13.2.3. Cancer
13.2.4. Others
13.3. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Technology, 2017–2028
13.3.1. 16s rRNA Sequencing
13.3.2. Metagenomic Sequencing
13.4. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
13.4.1. Gastrointestinal Disorders
13.4.2. Metabolic Disorders
13.4.3. Women's Health Disorders
13.4.4. Skin Disorders
13.4.5. Others
13.5. Middle East & Africa Human Microbiome Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Latin America Human Microbiome Market Attractiveness Analysis
13.6.1. By Indication
13.6.2. By Technology
13.6.3. By Therapeutic Area
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share / Position Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. AOBiome
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Strategic Overview
14.3.1.4. SWOT Analysis
14.3.2. Enterome Biosciences SA
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Strategic Overview
14.3.2.4. SWOT Analysis
14.3.3. Metabiomics Corp. (BioSpherex LLC)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Strategic Overview
14.3.3.4. SWOT Analysis
14.3.4. Microbiome Therapeutics LLC
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Strategic Overview
14.3.4.4. SWOT Analysis
14.3.5. Osel, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Strategic Overview
14.3.5.4. SWOT Analysis
14.3.6. Second Genome
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Strategic Overview
14.3.6.4. SWOT Analysis
14.3.7. Seres Therapeutics
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. Synthetic Biologics, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. Vedanta Biosciences
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.10. 4D Pharma
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.11. Ferring Pharmaceuticals
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. Strategic Overview
14.3.11.5. SWOT Analysis
List of Table
Table 1: Key Mergers and Acquisitions
Table 2: Global Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2017–2028
Table 3: Global Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 4: Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028
Table 5: Global Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2028
Table 6: Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Region, 2020-2028
Table 7: North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2017–2028
Table 8: North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 9: North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2028
Table 10: North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2026
Table 11: North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2028
Table 12: Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2017–2028
Table 13: Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 14: Europe Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 15: Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028
Table 16: Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country, 2020–2028
Table 17: Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Indication, 2017–2028
Table 18: Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 19: Asia Pacific Human Microbiome Diagnostic Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 20: Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028
Table 21: Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020–2028
Table 22: Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2017–2028
Table 23: Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 24: Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 25: Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028
Table 26: Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020–2028
Table 27: Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Indication, 2017–2028
Table 28: Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2028
Table 29: Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 30: Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2028
Table 31: Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020–2028
List of Figure
Figure 1: Global Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 2: Global Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2017–2028
Figure 3: Human Microbiome Diagnostic Market Value Share, by Indication, 2020
Figure 4: Human Microbiome Diagnostic Market Value Share, by Technology, 2020
Figure 5: Human Microbiome Therapeutics Market Value Share, by Therapeutic Area, 2020
Figure 6: Human Microbiome Therapeutics Market Value Share, by Region, 2020
Figure 7: Global Human Microbiome Diagnostic Market Value Share Analysis, by Indication, 2020 and 2028
Figure 8: Global GI & Metabolic Disorders Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 9: Global Women’s Health Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 10: Global Cancer Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 11: Global Others Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 12: Global Human Microbiome Diagnostic Market Attractiveness Analysis, by Indication, 2021-2028
Figure 13: Global Human Microbiome Diagnostic Market Value Share Analysis, by Technology, 2020 and 2028
Figure 14: Global Human Microbiome Diagnostic Market Attractiveness Analysis, by Technology, 2021-2028
Figure 15: Global Metagenomic Sequencing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 16: Global 16s rRNA Sequencing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 17: Global Human Microbiome Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2028
Figure 18: Global GI Disorders Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2028
Figure 19: Global Metabolic Disorders Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2028
Figure 20: Global Women’s Health Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2028
Figure 21: Global Skin Disorders Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2028
Figure 22: Global Others Market Size (US$ Mn) and Y-o-Y Growth (%), 2020–2028
Figure 23: Global Human Microbiome Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
Figure 24: Global Human Microbiome Diagnostics Market Value Share Analysis, by Region, 2020 and 2028
Figure 25: Global Human Microbiome Therapeutics Market Value Share Analysis, by Region, 2020 and 2028
Figure 26: Global Human Microbiome Diagnostics Market Attractiveness Analysis, by Region, 2021-2028
Figure 27: Global Human Microbiome Therapeutics Market Attractiveness Analysis, by Region, 2021-2028
Figure 28: North America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 29: North America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2017–2028
Figure 30: North America Diagnostics Market Attractiveness Analysis, by Country, 2021-2028
Figure 31: North America Therapeutics Market Attractiveness Analysis, by Country, 2021-2028
Figure 32: North America Diagnostic Market Value Share Analysis, by Indication, 2020 and 2028
Figure 33: North America Diagnostic Market Value Share Analysis, by Technology, 2020 and 2028
Figure 34: North America Diagnostic Market Value Share Analysis, by Country, 2020 and 2028
Figure 35: North America Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2028
Figure 36: North America Therapeutics Market Value Share Analysis, by Country, 2020 and 2028
Figure 37: North America Diagnostics Market Attractiveness Analysis, by Indication, 2021-2028
Figure 38: North America Diagnostics Market Attractiveness Analysis, by Technology, 2021-2028
Figure 39: North America Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
Figure 40: Europe Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 41: Europe Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2017–2028
Figure 42: Europe Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 43: Europe Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 44: Europe Diagnostic Market Value Share Analysis, by Indication, 2020 and 2028
Figure 45: Europe Diagnostic Market Value Share Analysis, by Technology, 2020 and 2028
Figure 46: Europe Diagnostic Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 47: Europe Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2028
Figure 48: Europe Therapeutics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 49: Europe Diagnostics Market Attractiveness Analysis, by Indication, 2021-2028
Figure 50: Europe Diagnostics Market Attractiveness Analysis, by Technology, 2021-2028
Figure 51: Europe Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
Figure 52: Asia Pacific Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 53: Asia Pacific Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2017–2028
Figure 54: Asia Pacific Diagnostics Market Attractiveness Analysis, by Country, 2021-2028
Figure 55: Asia Pacific Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 56: Asia Pacific Diagnostic Market Value Share Analysis, by Indication, 2020 and 2028
Figure 57: Asia Pacific Diagnostic Market Value Share Analysis, by Technology, 2020 and 2028
Figure 58: Asia Pacific Diagnostic Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 59: Asia Pacific Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2028
Figure 60: Asia Pacific Therapeutics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 61: Asia Pacific Diagnostics Market Attractiveness Analysis, by Indication, 2021-2028
Figure 62: Asia Pacific Diagnostics Market Attractiveness Analysis, by Technology, 2021-2028
Figure 63: Asia Pacific Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
Figure 64: Latin America Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 65: Latin America Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2017–2028
Figure 66: Latin America Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 67: Latin America Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 68: Latin America Diagnostics Market Value Share Analysis, by Indication, 2020 and 2028
Figure 69: Latin America Diagnostics Market Value Share Analysis, by Technology, 2020 and 2028
Figure 70: Latin America Diagnostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 71: Latin America Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2028
Figure 72: Latin America Therapeutics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 73: Latin America Diagnostics Market Attractiveness Analysis, by Indication, 2021-2028
Figure 74: Latin America Diagnostics Market Attractiveness Analysis, by Technology, 2021-2028
Figure 75: Latin America Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
Figure 76: Middle East & Africa Human Microbiome Diagnostics Market Size (US$ Mn) Forecast, 2017–2028
Figure 77: Middle East & Africa Human Microbiome Therapeutics Market Size (US$ Mn) Forecast, 2017–2028
Figure 78: Middle East & Africa Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 79: Middle East & Africa Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 80: Middle East & Africa Diagnostics Market Value Share Analysis, by Indication, 2020 and 2028
Figure 81: Middle East & Africa Diagnostics Market Value Share Analysis, by Technology, 2020 and 2028
Figure 82: Middle East & Africa Diagnostics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 83: Middle East & Africa Therapeutics Market Value Share Analysis, by Therapeutic Area, 2020 and 2028
Figure 84: Middle East & Africa Therapeutics Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 85: MEA Diagnostics Market Attractiveness Analysis, by Indication, 2021-2028
Figure 86: MEA Diagnostics Market Attractiveness Analysis, by Technology, 2021-2028
Figure 87: MEA Therapeutics Market Attractiveness Analysis, by Therapeutic Area, 2021-2028
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Human Microbiome Market
